Free Trial
ASX:ATX

Amplia Therapeutics (ATX) Stock Price, News & Analysis

Amplia Therapeutics logo

About Amplia Therapeutics Stock (ASX:ATX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
77,249 shs
Average Volume
N/A
Market Capitalization
A$30.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amplia Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATX Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

ATX Stock Analysis - Frequently Asked Questions

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:ATX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$4.50 million
Net Margins
-101.14%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$4.45 million
Price / Cash Flow
4.88
Book Value
A$0.06 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$30.65 million
Optionable
Not Optionable
Beta
0.72
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ASX:ATX) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners